These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9629998

  • 1. CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze.
    Wilson J, Watson WP, Little HJ.
    Psychopharmacology (Berl); 1998 May; 137(2):120-31. PubMed ID: 9629998
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anxiolytic effects of CCK-B antagonists.
    Costall B, Domeney AM, Hughes J, Kelly ME, Naylor RJ, Woodruff GN.
    Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S, Soosaar A, Võikar V, Bourin M, Vasar E.
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [Abstract] [Full Text] [Related]

  • 8. Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze.
    Gatch MB, Wallis CJ, Lal H.
    Alcohol; 1999 Nov; 19(3):207-11. PubMed ID: 10580509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal.
    Gatch MB, Wallis CJ, Lal H.
    Alcohol; 1999 Aug; 19(1):9-14. PubMed ID: 10487382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.
    Bickerdike MJ, Fletcher A, Marsden CA.
    Neuropharmacology; 1995 Jul; 34(7):805-11. PubMed ID: 8532148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.
    Xu XJ, Wiesenfeld-Hallin Z, Hughes J, Horwell DC, Hökfelt T.
    Br J Pharmacol; 1992 Mar; 105(3):591-6. PubMed ID: 1628146
    [Abstract] [Full Text] [Related]

  • 15. Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze.
    Miyasaka K, Kobayashi S, Ohta M, Kanai S, Yoshida Y, Nagata A, Matsui T, Noda T, Takiguchi S, Takata Y, Kawanami T, Funakoshi A.
    Neurosci Lett; 2002 Dec 25; 335(2):115-8. PubMed ID: 12459512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences in Behavioral Responding in Adult and Aged Rats Following Chronic Ethanol Exposure.
    Novier A, Ornelas LC, Diaz-Granados JL, Matthews DB.
    Alcohol Clin Exp Res; 2016 Jul 25; 40(7):1462-72. PubMed ID: 27218698
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors.
    Gustafsson H, de Araújo Lucas G, Schött E, Stiller CO, Alster P, Wiesenfeld-Hallin Z, Brodin E.
    Brain Res; 1998 Apr 20; 790(1-2):141-50. PubMed ID: 9593865
    [Abstract] [Full Text] [Related]

  • 20. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S, Männistö PT, Bourin M, Shlik J, Vasar V, Vasar E.
    J Psychiatry Neurosci; 2000 Jan 20; 25(1):33-42. PubMed ID: 10721682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.